Pfizer discloses updated portfolio positions in 13F filing: Maintained ALLO PYXS CRBU ARVN CRDF SPRO WVE holdings, Exited QTTB, Lowered ORIC ZURA NXTC (26.80 +0.49)
Highlights from Q2 2026 filing as compared to Q1 2026 (all amounts are approximate):
- Maintained: ALLO (22.0 mln shares), PYXS (7.0 mln), CRBU (4.7 mln), ARVN (3.5 mln), CRDF (2.4 mln), SPRO (2.4 mln), WVE (1.9 mln)
- Exited: QTTB (102K)
- Decreased: ORIC (373K from 4.8 mln), ZURA (539K from 2.8 mln), NXTC (44K from 153K)